+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Europe Cell Therapy Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Therapy Type; Product; Technology; Application; End User, and Country.

  • PDF Icon

    Report

  • 165 Pages
  • February 2021
  • Region: Europe
  • The Insight Partners
  • ID: 5295143
Allogeneic Segment Held Largest Share of Europe Cell therapy Market in 2019

According to our new market research study on “Europe Cell therapy Market to 2027 - Regional Analysis and Forecast - by therapy type, product, technology, application, end user,” the market is expected to reach US$ 3,610.7 million by 2027 from US$ 2,125.7 million in 2019; it is anticipated to grow at a CAGR of 6.9% during 2019-2027. The report provides trends prevailing in the Europe cell therapy market, and drivers and restraints pertaining to the market growth.

The Europe cell therapy market based on therapy type is segmented into allogeneic, and autologous. In 2019, the allogeneic segment accounted for the highest share owing to the availability of substantial number of approved products for clinical use. For instance, in 2018, Alofisel developed by TiGenix (Takeda) is the first allogeneic stem cell-based therapy approved for use in Europe. However, the autologous segment is likely register the highest CAGR in the market during the forecast period.

The growth of the Europe cell therapy market is mainly attributed to increasing prevalence of chronic diseases, rising adoption of regenerative medicines, and increasing number of approvals for cell-based therapies. However, high cost of cell therapy manufacturing is the major factor hindering the market growth in Europe.

A few of the leading companies operating in the Europe cell therapy market are Vericel Corporation, MEDIPOST, NuVasive, Inc., Mesoblast Limited, Smith & Nephew, Bristol-Myers Squibb Company, Cells for Cells, Stemedica Cell Technologies, Inc.. and others.

The report segments Europe cell therapy market as follows:

Europe Cell therapy Market - By Therapy Type
  • Allogeneic
  • Autologous

Europe Cell therapy Market - By Product
  • Consumables
  • Equipment
  • Systems and Software

Europe Cell therapy Market - By Technology
  • Viral Vector Technology
  • Genome Editing Technology
  • Somatic Cell Technology
  • Cell Immortalization Technology
  • Cell Plasticity Technology
  • Three-Dimensional Technology

Europe Cell therapy Market - By Application
  • Oncology
  • Cardiovascular
  • Orthopedic
  • Wound Management
  • Other Applications

Europe Cell therapy Market - By End User
  • Research Institutes
  • Hospitals
  • Others

Europe Cell therapy Market - By Country
  • Europe
  • Germany
  • France
  • Italy
  • UK
  • Spain

Reasons to Buy
It provides understanding of the Europe, Cell therapy market landscape and identifies Cell therapy market segments that are most likely to guarantee a strong return.It guides

Stay ahead of the race by comprehending the ever-changing competitive landscape for the Europe Cell therapy market.It helps

Efficiently plan merger and acquisition, and partnership deals in the Cell therapy market by identifying market segments with the most promising probable sales.

It facilitates knowledgeable business decision-making through perceptive and comprehensive analysis of Cell therapy market performance of various segments pertaining to the Europe Cell therapy market.

It provides Cell therapy market revenue forecast of the market based on various segments for the period from 2019 to 2027.

Table of Contents

1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Cell Therapy Market - By Therapy Type
1.3.2 Europe Cell Therapy Market - By Product
1.3.3 Europe Cell Therapy Market - By Technology
1.3.4 Europe Cell Therapy Market - By Application
1.3.5 Europe Cell Therapy Market - By End User
1.3.6 Europe Cell Therapy Market - By Geography
2. Cell Therapy Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Cell therapy- Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Europe- PEST Analysis
Expert Opinions
5. Europe Cell Therapy Market - Key Industry Dynamics
5.1 Key Market Drivers
5.1.1 Increasing Prevalence of Chronic Diseases
5.1.2 Rising Adoption of Regenerative Medicines
5.1.3 Increasing Number of Approvals for Cell-Based Therapies
5.2 Key Market Restraints
5.2.1 High Cost of Cell Therapy Manufacturing
5.3 Key Market Opportunities
5.3.1 Increasing focus on personalized medicine
5.4 Future Trends
5.4.1 Shift Toward Automated Cell Therapy Manufacturing
5.5 Impact Analysis of Drivers and Restraints
6. Cell therapy Market - Europe Analysis
6.1 Europe Cell therapy Market Revenue Forecast And Analysis
7. Cell therapy Market Analysis - By Therapy Type
7.1 Overview
7.2 Cell therapy Market Revenue Share, by Therapy Type (2019 and 2027)
7.3 Allogeneic
7.3.1 Overview
7.3.2 Allogeneic: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
7.4 Autologous
7.4.1 Overview
7.4.2 Autologous: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
8. Cell therapy Market Analysis - By Product
8.1 Overview
8.2 Cell therapy Market Revenue Share, by Product (2019 and 2027)
8.3 Consumables
8.3.1 Overview
8.3.2 Consumables: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
8.4 Equipment
8.4.1 Overview
8.4.2 Equipment: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
8.5 Systems and Software
8.5.1 Overview
8.5.2 Systems and Software: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
9. Cell therapy Market Analysis - By Technology
9.1 Overview
9.2 Cell therapy Market Revenue Share, by Technology (2019 and 2027)
9.3 Viral Vector Technology
9.3.1 Overview
9.3.2 Viral Vector Technology: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
9.4 Genome Editing Technology
9.4.1 Overview
9.4.2 Genome Editing Technology: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
9.5 Somatic Cell Technology
9.5.1 Overview
9.5.2 Somatic Cell Technology: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
9.6 Cell Immortalization Technology
9.6.1 Overview
9.6.2 Cell Immortalization Technology: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
9.7 Cell Plasticity Technology
9.7.1 Overview
9.7.2 Cell Plasticity Technology: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
9.8 Three-Dimensional Technology
9.8.1 Overview
9.8.2 Three-Dimensional Technology: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
10. Cell therapy Market Analysis - By Application
10.1 Overview
10.2 Cell therapy Market Revenue Share, by Application (2019 and 2027)
10.3 Oncology
10.3.1 Overview
10.3.2 Oncology: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
10.4 Cardiovascular
10.4.1 Overview
10.4.2 Cardiovascular: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
10.5 Orthopedic
10.5.1 Overview
10.5.2 Orthopedic: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
10.6 Wound Management
10.6.1 Overview
10.6.2 Wound Management: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
10.7 Other Applications
10.7.1 Overview
10.7.2 Other Applications: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
11. Cell therapy Market Analysis - By End User
11.1 Overview
11.2 Cell therapy Market Share, by End User, 2019 and 2027, (%)
11.3 Hospitals
11.3.1 Overview
11.3.2 Hospitals: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
11.4 Research Institutes
11.4.1 Overview
11.4.2 Research Institutes: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
11.5 Others
11.5.1 Overview
11.5.2 Others: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
12. Cell therapy Market - Geographic Analysis
12.1 Europe: Cell therapy Market
12.1.1 Overview
12.1.2 Europe: Cell Therapy Market - Revenue and Forecast to 2027 (USD Million)
12.1.3 Europe: Cell Therapy Market, by Therapy Type - Revenue and Forecast to 2027 (USD Million)
12.1.4 Europe: Cell Therapy Market, by Product - Revenue and Forecast to 2027 (USD Million)
12.1.5 Europe: Cell Therapy Market, by Technology - Revenue and Forecast to 2027 (USD Million)
12.1.6 Europe: Cell Therapy Market, by Application - Revenue and Forecast to 2027 (USD Million)
12.1.7 Europe: Cell Therapy Market, By End User - Revenue and Forecast to 2027 (USD Million)
12.1.8 Europe: Cell therapy Market, by Country, 2019 & 2027 (%)
12.1.9 Germany: Cell therapy Market - Revenue and Forecast to 2027 (USD Million)
12.1.9.1 Germany: Cell therapy Market - Revenue and Forecast to 2027 (USD Million)
12.1.9.2 Germany: Cell Therapy Market, by Therapy Type - Revenue and Forecast to 2027 (USD Million)
12.1.9.3 Germany: Cell Therapy Market, by Product - Revenue and Forecast to 2027 (USD Million)
12.1.9.4 Germany: Cell Therapy Market, by Technology - Revenue and Forecast to 2027 (USD Million)
12.1.9.5 Germany: Cell Therapy Market, by Application - Revenue and Forecast to 2027 (USD Million)
12.1.9.6 Germany: Cell Therapy Market, By End User - Revenue and Forecast to 2027 (USD Million)
12.1.10 France: Cell therapy Market - Revenue and Forecast to 2027 (USD Million)
12.1.10.1 France: Cell therapy Market - Revenue and Forecast to 2027 (USD Million)
12.1.10.2 France: Cell Therapy Market, by Therapy Type - Revenue and Forecast to 2027 (USD Million)
12.1.10.3 France: Cell Therapy Market, by Product - Revenue and Forecast to 2027 (USD Million)
12.1.10.4 France: Cell Therapy Market, by Technology - Revenue and Forecast to 2027 (USD Million)
12.1.10.5 France: Cell Therapy Market, by Application - Revenue and Forecast to 2027 (USD Million)
12.1.10.6 France: Cell Therapy Market, By End User - Revenue and Forecast to 2027 (USD Million)
12.1.11 UK: Cell therapy Market - Revenue and Forecast to 2027 (USD Million)
12.1.11.1 UK: Cell therapy Market - Revenue and Forecast to 2027 (USD Million)
12.1.11.2 UK: Cell Therapy Market, by Therapy Type - Revenue and Forecast to 2027 (USD Million)
12.1.11.3 UK: Cell Therapy Market, by Product - Revenue and Forecast to 2027 (USD Million)
12.1.11.4 UK: Cell Therapy Market, by Technology - Revenue and Forecast to 2027 (USD Million)
12.1.11.5 UK: Cell Therapy Market, by Application - Revenue and Forecast to 2027 (USD Million)
12.1.11.6 UK: Cell Therapy Market, By End User - Revenue and Forecast to 2027 (USD Million)
12.1.12 Italy: Cell therapy Market - Revenue and Forecast to 2027 (USD Million)
12.1.12.1 Italy: Cell therapy Market - Revenue and Forecast to 2027 (USD Million)
12.1.12.2 Italy: Cell Therapy Market, by Therapy Type - Revenue and Forecast to 2027 (USD Million)
12.1.12.3 Italy: Cell Therapy Market, by Product - Revenue and Forecast to 2027 (USD Million)
12.1.12.4 Italy: Cell Therapy Market, by Technology - Revenue and Forecast to 2027 (USD Million)
12.1.12.5 Italy: Cell Therapy Market, by Application - Revenue and Forecast to 2027 (USD Million)
12.1.12.6 Italy: Cell Therapy Market, By End User - Revenue and Forecast to 2027 (USD Million)
12.1.13 Spain: Cell therapy Market - Revenue and Forecast to 2027 (USD Million)
12.1.13.1 Spain: Cell therapy Market - Revenue and Forecast to 2027 (USD Million)
12.1.13.2 Spain: Cell Therapy Market, by Therapy Type - Revenue and Forecast to 2027 (USD Million)
12.1.13.3 Spain: Cell Therapy Market, by Product - Revenue and Forecast to 2027 (USD Million)
12.1.13.4 Spain: Cell Therapy Market, by Technology - Revenue and Forecast to 2027 (USD Million)
12.1.13.5 Spain: Cell Therapy Market, by Application - Revenue and Forecast to 2027 (USD Million)
12.1.13.6 Spain: Cell Therapy Market, By End User - Revenue and Forecast to 2027 (USD Million)
13. Impact of COVID-19 Pandemic on Europe Cell Therapy Market
13.1 Europe: Impact Assessment of COVID-19 Pandemic
14. Cell Therapy Market- Industry Landscape
14.1 Overview
14.2 Growth Strategies Done by the Companies in the Market, (%)
14.3 Organic Developments
14.3.1 Overview
14.4 Inorganic Developments
14.4.1 Overview
15. Company Profiles
15.1 Vericel Corporation
15.1.1 Key Facts
15.1.2 Business Description
15.1.3 Products and Services
15.1.4 Financial Overview
15.1.5 SWOT Analysis
15.1.6 Key Developments
15.2 MEDIPOST
15.2.1 Key Facts
15.2.2 Business Description
15.2.3 Products and Services
15.2.4 Financial Overview
15.2.5 SWOT Analysis
15.2.6 Key Developments
15.3 NuVasive, Inc.
15.3.1 Key Facts
15.3.2 Business Description
15.3.3 Products and Services
15.3.4 Financial Overview
15.3.5 SWOT Analysis
15.3.6 Key Developments
15.4 Mesoblast Limited
15.4.1 Key Facts
15.4.2 Business Description
15.4.3 Products and Services
15.4.4 Financial Overview
15.4.5 SWOT Analysis
15.4.6 Key Developments
15.5 Smith & Nephew
15.5.1 Key Facts
15.5.2 Business Description
15.5.3 Products and Services
15.5.4 Financial Overview
15.5.5 SWOT Analysis
15.5.6 Key Developments
15.6 Bristol-Myers Squibb Company
15.6.1 Key Facts
15.6.2 Business Description
15.6.3 Products and Services
15.6.4 Financial Overview
15.6.5 SWOT Analysis
15.6.6 Key Developments
15.7 Cells for Cells
15.7.1 Key Facts
15.7.2 Business Description
15.7.3 Products and Services
15.7.4 Financial Overview
15.7.5 SWOT Analysis
15.7.6 Key Developments
15.8 Stemedica Cell Technologies, Inc
15.8.1 Key Facts
15.8.2 Business Description
15.8.3 Products and Services
15.8.4 Financial Overview
15.8.5 SWOT Analysis
15.8.6 Key Developments
16. Appendix
16.1 About the Publisher
16.2 Glossary of Terms
List of Tables
Table 1. Europe: Cell Therapy Market, by Therapy Type - Revenue and Forecast to 2027 (USD Million)
Table 2. Europe: Cell Therapy Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 3. Europe: Cell Therapy Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 4. Europe: Cell Therapy Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 5. Europe: Cell Therapy Market, By End User - Revenue and Forecast to 2027 (USD Million)
Table 6. Germany: Cell Therapy Market, by Therapy Type - Revenue and Forecast to 2027 (USD Million)
Table 7. Germany: Cell Therapy Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 8. Germany: Cell Therapy Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 9. Germany: Cell Therapy Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 10. Germany: Cell Therapy Market, By End User - Revenue and Forecast to 2027 (USD Million)
Table 11. France: Cell Therapy Market, by Therapy Type - Revenue and Forecast to 2027 (USD Million)
Table 12. France: Cell Therapy Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 13. France: Cell Therapy Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 14. France: Cell Therapy Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 15. France: Cell Therapy Market, By End User - Revenue and Forecast to 2027 (USD Million)
Table 16. UK: Cell Therapy Market, by Therapy Type - Revenue and Forecast to 2027 (USD Million)
Table 17. UK: Cell Therapy Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 18. UK: Cell Therapy Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 19. UK: Cell Therapy Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 20. UK: Cell Therapy Market, By End User - Revenue and Forecast to 2027 (USD Million)
Table 21. Italy: Cell Therapy Market, by Therapy Type - Revenue and Forecast to 2027 (USD Million)
Table 22. Italy: Cell Therapy Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 23. Italy: Cell Therapy Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 24. Italy: Cell Therapy Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 25. Italy: Cell Therapy Market, By End User - Revenue and Forecast to 2027 (USD Million)
Table 26. Spain: Cell Therapy Market, by Therapy Type - Revenue and Forecast to 2027 (USD Million)
Table 27. Spain: Cell Therapy Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 28. Spain: Cell Therapy Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 29. Spain: Cell Therapy Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 30. Spain: Cell Therapy Market, By End User - Revenue and Forecast to 2027 (USD Million)
Table 31. Organic Developments Done By Companies
Table 32. Inorganic Developments Done By Companies
Table 33. Glossary of Terms, Cell therapy Market
List of Figures
Figure 1. Cell Therapy Market Segmentation
Figure 2. Cell Therapy Market, By Region
Figure 3. Europe Cell Therapy Market Overview
Figure 4. The Autologous Segment Is Expected To Grow Faster By Therapy Type Segment In Cell therapy Market
Figure 5. Europe Region Is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Europe Cell therapy Market- Leading Country Markets (USD Million)
Figure 7. Europe PEST Analysis
Figure 8. Cell Therapy Market Impact Analysis of Driver and restraint
Figure 9. Europe Cell therapy Market - Revenue Forecast And Analysis - 2019- 2027
Figure 10. Cell therapy Market Revenue Share, by Therapy Type (2019 and 2027)
Figure 11. Allogeneic: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
Figure 12. Autologous: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
Figure 13. Cell therapy Market Revenue Share, by Product (2019 and 2027)
Figure 14. Consumables: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
Figure 15. Equipment: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
Figure 16. Systems and Software: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
Figure 17. Cell therapy Market Revenue Share, by Technology (2019 and 2027)
Figure 18. Viral Vector Technology: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
Figure 19. Genome Editing Technology: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
Figure 20. Somatic Cell Technology: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
Figure 21. Cell Immortalization Technology: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
Figure 22. Cell Plasticity Technology: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
Figure 23. Three-Dimensional Technology: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
Figure 24. Cell therapy Market Revenue Share, by Application (2019 and 2027)
Figure 25. Oncology: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
Figure 26. Cardiovascular: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
Figure 27. Orthopedic: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
Figure 28. Wound Management: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
Figure 29. Other Applications: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
Figure 30. Cell therapy Market Share, by End User, 2019 and 2027 (%)
Figure 31. Hospitals Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
Figure 32. Research Institutes: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
Figure 33. Others: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
Figure 34. Europe: Cell therapy Market, by Key Country - Revenue (2019) (USD Million)
Figure 35. Europe: Cell Therapy Market Revenue and Forecast to 2027 (USD Million)
Figure 36. Europe: Cell therapy Market, by Country, 2019 & 2027 (%)
Figure 37. Germany: Cell therapy Market - Revenue and Forecast to 2027 (USD Million)
Figure 38. France: Cell therapy Market - Revenue and Forecast to 2027 (USD Million)
Figure 39. UK: Cell therapy Market - Revenue and Forecast to 2027 (USD Million)
Figure 40. Italy: Cell therapy Market - Revenue and Forecast to 2027 (USD Million)
Figure 41. Spain: Cell therapy Market - Revenue and Forecast to 2027 (USD Million)
Figure 42. Impact of COVID-19 Pandemic in European Country Markets
Figure 43. Growth Strategies Done by the Companies in the Market, (%)

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Vericel Corporation
  • MEDIPOST
  • NuVasive, Inc.
  • Mesoblast Limited
  • Smith & Nephew
  • Bristol-Myers Squibb Company
  • Cells for Cells
  • Stemedica Cell Technologies, Inc.